Recursion

Recursion is a TechBio company pioneering AI-driven drug discovery, using biological imaging, machine learning, and large-scale data to decode biology and develop novel medicines faster. In November 2024, Recursion completed its merger with Exscientia, combining the two AI drug-discovery firms into an end-to-end platform headquartered in Salt Lake City.